Innocoll AG (INNL) Announces Cogenzia Gentamicin Received FDA QIDP Designation as Adjunctive Diabetic Foot Infection Treatment
Tweet Send to a Friend
Innocoll AG (NASDAQ: INNL) announced that the Cogenzia gentamicin collagen matrix has received Qualified Infectious Disease Product (QIDP) designation for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
